Diagnostic Application of Targeted Next-Generation Sequencing of 80 Genes Associated with Disorders of Sexual Development

Citations Over TimeTop 14% of 2017 papers

Abstract

Abstract Disorders of sexual development (DSD) are estimated to occur in 1 of 4500 births. Since the genetic etiology of DSD is highly heterogeneous, obtaining a definitive molecular diagnosis by single gene test is challenging. Utilizing a high-throughput sequencing upfront is proposed as an efficient approach to aid in the diagnosis. This study aimed to examine the diagnostic yield of next-generation sequencing in DSD. 32 DSD patients that previously received clinical examinations and single gene tests were selected, with or without a diagnosis. Prior single gene tests were masked, and then samples went through targeted next-generation sequencing of 80 genes from which the diagnostic yield was assessed. A likely diagnosis, with pathogenic or likely pathogenic variants identified, was obtained from nine of the 32 patients (i.e., 28.1%, versus 10% by single gene tests). In another five patients (15.6%), variants of uncertain significance were found. Among 18 variants identified (i.e., 17 single nucleotide variants and one small deletion), eight had not been previously reported. This study supports the notion that next-generation sequencing can be an efficient tool in the clinical diagnosis and variant discovery in DSD.

Related Papers

• → Genetic testing of adults with intellectual disability(2012)10 cited
• → Genetic testing of familial hypercholesterolemia in a real clinical setting(2016)9 cited
• [Gene mutation and genetic counseling].(2009)
• → Genetic diagnosis of inherited peripheral neuropathies using gene panel testing: The utility of follow up familial testing in 4 years of experience(2017)
• → [Ethical Issues of Genetic Testing towards Hereditary Neurological Disorders].(2020)